Overview
Corticale S.r.l. is a neurotechnology company developing next-generation high-density CMOS-based neural interfaces for advanced Brain-Computer Interface (BCI) applications. Leveraging its proprietary SiNAPS technology, Corticale has created implantable neural devices capable of recording neural activity through more than 1,000 contacts per implant, enabling unprecedented signal resolution, scalability, and data quality. Operating at the intersection of neuroscience, microelectronics, and artificial intelligence, the company is advancing a new generation of high-performance BCI platforms aimed at restoring communication and motor functions in patients affected by severe neurological conditions.
More in Neurotechnology
Latest industry news
China's Neurotech Ambitions Signal a New Frontier in the Global Brain Race
2026-10-18 · Industry
Functional Ultrasound BCIs Cross a Threshold: From Brain Reading to Two-Way Control
2026-10-17 · Research
Visual Cues Are Quietly Skewing BCI Accuracy Scores, and the Field Is Taking Notice
2026-10-16 · Research
ReVision Implant Secures €4 Million to Advance Neural Vision Restoration Technology
2026-10-15 · Funding
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →